Resting beta-cells - A functional reserve?

Diabetes and Metabolism

Volumn 42, Issue 3, 2016, Pages 157-161

  Hara, M ^a   Fowler, J L ^a   Bell, G I ^a   Philipson, L H ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

Beta cells; Islet; Pancreas; Resting beta cells

Indexed keywords

HEMOGLOBIN A1C; INSULIN;

BRAIN CELL; CELL ACTIVITY; CELL DEATH; CELL LOSS; CELL SURVIVAL; ENDOPLASMIC RETICULUM; ENDOPLASMIC RETICULUM STRESS; GLUCOSE BLOOD LEVEL; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; INSULIN SYNTHESIS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL FUNCTION; REST; REVIEW; SLEEP; SLEEP WAKING CYCLE; ANIMAL; CELL COUNT; CELL CYCLE; CELL PROTECTION; PATHOLOGY; PHYSIOLOGY; REGENERATION; SECRETION (PROCESS);

ANIMALS; CELL COUNT; CELL CYCLE; CYTOPROTECTION; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; HUMANS; INSULIN; INSULIN-SECRETING CELLS; REGENERATION;

EID: 84955615049     PISSN: 12623636     EISSN: 18781780     Source Type: Journal    
DOI: 10.1016/j.diabet.2016.01.001     Document Type: Review

References (49)

1. Ishii Y., Hasegawa E. The mechanism underlying the regulation of work-related behaviors in the monomorphic ant, Myrmica kotokui. J Ethol 2013, 31:61-69.
2. Vyazovskiy V.V., Olcese U., Hanlon E.C., Nir Y., Cirelli C., Tononi G. Local sleep in awake rats. Nature 2011, 472:443-447.
3. Cirelli C., Tononi G. Is sleep essential?. PLoS Biol 2008, 26:6. [e216].
4. Tononi G., Cirelli C. Sleep function and synaptic homeostasis. Sleep Med Rev 2006, 10:49-62.
5. Olsson R., Carlsson P.O. A low-oxygenated subpopulation of pancreatic islets constitutes a functional reserve of endocrine cells. Diabetes 2011, 60:2068-2075.
6. Grapov D., Fahrmann J., Hwang J., Poudel A., Jo J., Periwal V., et al. Diabetes associated metabolomic perturbations in NOD mice. Metabolomics 2015, 11:425-437.
7. Fahrmann J., Grapov D., Yang J., Hammock B., Fiehn O., Bell G.I., et al. Systemic alterations in the metabolome of diabetic NOD mice delineate increased oxidative stress accompanied by reduced inflammation and hypertriglyceremia. Am J Physiol Endocrinol Metab 2015, 308:E978-E989.
8. Gepts W. Pathologic anatomy of the pancreas in juvenile diabetes mellitus. Diabetes 1965, 14:619-633.
9. Saito K., Abe K., Ito T. Change in plasma renin activity by cold storage of plasma in normal subjects and patients with essential hypertension and primary aldosteronism. Tohoku J Exp Med 1979, 128:13-18.
10. Leonardi O., Mints G., Hussain M.A. Beta-cell apoptosis in the pathogenesis of human type 2 diabetes mellitus. Eur J Endocrinol 2003, 149:99-102.
11. Meier J.J., Breuer T.G., Bonadonna R.C., Tannapfel A., Uhl W., Schmidt W.E., et al. Pancreatic diabetes manifests when beta cell area declines by approximately 65% in humans. Diabetologia 2012, 55:1346-1354.
12. Larsen MO1, Rolin B., Wilken M., Carr R.D., Gotfredsen C.F. Measurements of insulin secretory capacity and glucose tolerance to predict pancreatic beta-cell mass in vivo in the nicotinamide/streptozotocin Göttingen minipig, a model of moderate insulin deficiency and diabetes. Diabetes 2003, 52:118-123.
13. Kjems L.L., Kirby B.M., Welsh E.M., Veldhuis J.D., Straume M., McIntyre S.S., et al. Decrease in beta-cell mass leads to impaired pulsatile insulin secretion, reduced postprandial hepatic insulin clearance, and relative hyperglucagonemia in the minipig. Diabetes 2001, 50:2001-2012.
14. McCulloch D.K., Koerker D.J., Kahn S.E., Bonner-Weir S., Palmer J.P. Correlations of in vivo beta-cell function tests with beta-cell mass and pancreatic insulin content in streptozocin-administered baboons. Diabetes 1991, 40:673-679.
15. Bonner-Weir S., Trent D.F., Weir G.C. Partial pancreatectomy in the rat and subsequent defect in glucose-induced insulin release. J Clin Invest 1983, 71:1544-1553.
16. Tominaga M., Maruyama H., Bolli G., Helderman J.H., Unger R.H. Simulation of the normal glucopenia-induced decline in insulin partially restores the glucagon response to glucopenia in isolated perfused pancreata of streptozotocin-diabetic rats. Endocrinology 1986, 118:886-887.
17. Talchai C., Xuan S., Lin H.V., Sussel L., Accili D. Pancreatic β cell dedifferentiation as a mechanism of diabetic β cell failure. Cell 2012, 150:1223-1234.
18. Rahier J., Guiot Y., Goebbels R.M., Sempoux C., Henquin J.C. Pancreatic β-cell mass in European subjects with type 2 diabetes. Diabetes Obes Metab 2008, 10:32-42.
19. Yoon K.H., Ko S.H., Cho J.H., Lee J.M., Ahn Y.B., Song K.H., et al. Selective beta-cell loss and alpha-cell expansion in patients with type 2 diabetes mellitus in Korea. J Clin Endocrinol Metab 2003, 88:2300-2308.
20. Clark A., Wells C.A., Buley I.D., Cruickshank J.K., Vanhegan R.I., Matthews D.R., et al. Islet amyloid, increased A-cells, reduced B-cells and exocrine fibrosis: quantitative changes in pancreas in type 2 diabetes. Diabetes Res 1988, 9:151-159.
21. Sakuraba H., Mizukami H., Yagihashi N., Wada R., Hanyu C., Yagihashi S. Reduced beta-cell mass and expression of oxidative stress-related DNA damage in the islet of Japanese type II diabetic patients. Diabetologia 2002, 45:85-96.
22. Butler A.E., Janson J., Bonner-Weir S., Ritzel R., Rizza R.A., Butler P.C. Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes 2003, 52:102-110.
23. Maclean N., Ogilvie R.F. Quantitative estimation of the pancreatic islet tissue in diabetic subjects. Diabetes 1995, 4:367-376.
24. Saito K., Yaginuma N., Takahashi T. Differential volumetry of A, B and D cells in the pancreatic islets of diabetic and nondiabetic subjects. Tohoku J Exp Med 1979, 129:273-283.
25. Stefan Y., Orci L., Malaisse-Lagae F., Perrelet A., Patel Y., Unger R.H. Quantitation of endocrine cell content in the pancreas of nondiabetic and diabetic humans. Diabetes 1982, 31:694-700.
26. Klöppel G., Lohr M., Habich K., Oberholzer M., Heitz P.U. Islet pathology and the pathogenesis of type 1 and type 2 diabetes revisited. Surv Synth Pathol Res 1985, 4:110-125.
27. Kilimnik G., Zhao B., Jo J., et al. Altered islet composition and disproportionate loss of large islets in patients with type 2 diabetes. PLoS One 2011, 6:e27445.
28. Greeley S.A., Naylor R.N., Philipson L.H., Bell G.I. Neonatal diabetes: an expanding list of genes allows for improved diagnosis and treatment. Curr Diab Rep 2011, 11:519-532.
29. Hattersley A.T., Ashcroft F.M. Activating mutations in Kir6.2 and neonatal diabetes: new clinical syndromes, new scientific insights, and new therapy. Diabetes 2005, 54:2503-2513.
30. Gloyn A.L., Pearson E.R., Antcliff J.F., Proks P., Bruining G.J., Slingerland A.S., et al. Activating mutations in the gene encoding the ATP-sensitive potassium channel subunit Kir6.2 and permanent neonatal diabetes. N Engl J Med 2004, 350:1838-1849.
31. Thurber B.W., Carmody D., Tadie E.C., Pastore A.N., Dickens J.T., Wroblewski K.E., et al. Age at the time of sulfonylurea initiation influences treatment outcomes in KCNJ11-related neonatal diabetes. Diabetologia 2015, 58:1430-1435.
32. Støy J., Greeley S.A., Paz V.P., Ye H., Pastore A.N., Skowron K.B., et al. Diagnosis and treatment of neonatal diabetes: a United States experience. Pediatr Diabetes 2008, 9:450-459.
33. Rahier J., Goebbels R.M., Henquin J.C. Cellular composition of the human diabetic pancrease. Diabetologia 1983, 24:366-375.
34. Doniach I., Morgan A.G. Islets of Langerhans in juvenile diabetes mellitus. Clin Endocrinol 1973, 2:233-248.
35. Madsbad S., Faber O.K., Binder C., McNair P., Christiansen C., Transbøl I. Prevalence of residual beta-cell function ininsulin-dependent diabetics in relation to age at onset and duration of diabetes. Diabetes 1978, 27(Suppl 1):262-264.
36. Oram R., Jones A., Besser R.J., Knight B.A., Shields B.M., Brown R.J., et al. The majority of patients with long-duration type 1 diabetes are insulin microsecretors and have functioning beta cells. Diabetologia 2014, 57:187-191.
37. Levetan C. Distinctions between islet neogenesis and β-cell replication: Implications for reversal of type 1 and 2 diabetes. J Diabetes 2010, 2:76-84.
38. The Diabetes Control and Complications Trial Research Group Effect of intensive therapy on residual beta-cell function in patients with type 1 diabetes in the diabetes control and complications trial-a randomized, controlled trial. Ann Intern Med 1998, 128:517-523.
39. Meier J.J., Bhushan A., Butler A.E., Rizza R.A., Butler P.C. Sustained beta cell apoptosis in patients with long-standing type 1 diabetes: indirect evidence for islet regeneration?. Diabetologia 2005, 48:2221-2228.
40. The Diabetes Control and Complications Trial Research Group Effects of age, duration and treatment of insulindependent diabetes-mellitus on residual beta-cell function-observations during eligibility testing for the Diabetes Control and Complications Trial (DCCT). J Clin Endocrinol Metab 1987, 65:30-36.
41. Poudel A., Savari O., Striegel D.A., Periwal V., Taxy J., Millis J.M. Beta-cell destruction and preservation in childhood and adult onset type 1 diabetes. Endocrine 2015, 49:693-702.
42. Andralojc K.M., Mercalli A., Nowak K.W., Albarello L., Calcagno R., Luzi L., et al. Ghrelin-producing epsilon cells in the developing and adult human pancreas. Diabetologia 2009, 52:486-493.
43. Peterson C.A. Degranulation of beta cells of rat's pancreas by glucose correlated with alterations in glucose tolerance. Proc Soc Exp Biol Med 1949, 70:352-355.
44. Logothetopoulos J., Davidson J.K., Haist R.E., Best C.H. Degranulation of beta cells and loss of pancreatic insulin after infusions of insulin antibody or glucose. Diabetes 1965, 14:493-500.
45. Mingrone G., Castagneto-Gissey L. Mechanisms of early improvement/resolution of type 2 diabetes after bariatric surgery. Diabetes Metab 2009, 35:518-523.
46. Dixon J.B., le Roux C.W., Rubino F., Zimmet P. Bariatric surgery for type 2 diabetes. Lancet 2012, 379:2300-2311.
47. Bradley D., Magkos F., Klein S. Effects of bariatric surgery on glucose homeostasis and type 2 diabetes. Gastroenterology 2012, 143:897-912.
48. Andreelli F., Amouyal C., Magnan C., Mithieux G. What can bariatric surgery teach us about the pathophysiology of type 2 diabetes?. Diabetes Metab 2009, 35:499-507.
49. Mezza T., Muscogiuri G., Sorice G.P., Clemente G., Hu J., Pontecorvi A., et al. Insulin resistance alters islet morphology in nondiabetic humans. Diabetes 2014, 63:994-1007.